ecNumber*3.4.17.20#kmValue*-999#kmValueMaximum*#substrate*more#commentary*binding kinetics of recombinant wild-type and chimeric mutant isozymes to fibrinogen and plasminogen, overview#organism*Homo sapiens#ligandStructureId*#literature*652560#!ecNumber*3.4.17.20#kmValue*0.000005#kmValueMaximum*#substrate*hippuryl-arginine#commentary*mutant S90D/S94V/S90D, activation of TAFI by plasmin; wild-type, activation of TAFI by plasmin#organism*Homo sapiens#ligandStructureId*5050#literature*699871#!ecNumber*3.4.17.20#kmValue*0.000006#kmValueMaximum*#substrate*hippuryl-arginine#commentary*mutant R92K, activation of TAFI by plasmin; mutant S94V, activation of TAFI by plasmin#organism*Homo sapiens#ligandStructureId*5050#literature*699871#!ecNumber*3.4.17.20#kmValue*0.000007#kmValueMaximum*#substrate*hippuryl-arginine#commentary*mutant P91S, activation of TAFI by plasmin#organism*Homo sapiens#ligandStructureId*5050#literature*699871#!ecNumber*3.4.17.20#kmValue*0.000009#kmValueMaximum*#substrate*hippuryl-arginine#commentary*mutant S90P, activation of TAFI by plasmin#organism*Homo sapiens#ligandStructureId*5050#literature*699871#!ecNumber*3.4.17.20#kmValue*0.00001#kmValueMaximum*#substrate*hippuryl-arginine#commentary*mutant A93V, activation of TAFI by plasmin#organism*Homo sapiens#ligandStructureId*5050#literature*699871#!ecNumber*3.4.17.20#kmValue*0.000162#kmValueMaximum*#substrate*p-anisylazoformyl-L-arginine#commentary*mutant S90P, activation of TAFI by thrombin in the presence of thrombomodulin#organism*Homo sapiens#ligandStructureId*7011#literature*699871#!ecNumber*3.4.17.20#kmValue*0.000169#kmValueMaximum*#substrate*p-anisylazoformyl-L-arginine#commentary*mutant A93V, activation of TAFI by thrombin in the presence of thrombomodulin#organism*Homo sapiens#ligandStructureId*7011#literature*699871#!ecNumber*3.4.17.20#kmValue*0.000178#kmValueMaximum*#substrate*p-anisylazoformyl-L-arginine#commentary*wild-type, activation of TAFI by thrombin in the presence of thrombomodulin#organism*Homo sapiens#ligandStructureId*7011#literature*699871#!ecNumber*3.4.17.20#kmValue*0.000229#kmValueMaximum*#substrate*p-anisylazoformyl-L-arginine#commentary*mutant R92K, activation of TAFI by thrombin in the presence of thrombomodulin#organism*Homo sapiens#ligandStructureId*7011#literature*699871#!ecNumber*3.4.17.20#kmValue*0.000232#kmValueMaximum*#substrate*p-anisylazoformyl-L-arginine#commentary*mutant S94V, activation of TAFI by thrombin in the presence of thrombomodulin#organism*Homo sapiens#ligandStructureId*7011#literature*699871#!ecNumber*3.4.17.20#kmValue*0.012#kmValueMaximum*#substrate*biotinyl-(epsilon-aminocaproic acid)-(epsilon-aminocaproic acid)-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Arg-OH#commentary*room temperature#organism*Homo sapiens#ligandStructureId*33949#literature*649320#!ecNumber*3.4.17.20#kmValue*0.02#kmValueMaximum*#substrate*N-benzoyl-2'-cyano-L-Phe-L-Arg#commentary*in 50 mM HEPES (pH 8.0) at 25&deg;C#organism*Homo sapiens#ligandStructureId*40532#literature*707113#!ecNumber*3.4.17.20#kmValue*0.84#kmValueMaximum*#substrate*N-benzoyl-Gly-L-Arg#commentary*in 50 mM HEPES (pH 8.0) at 25&deg;C#organism*Homo sapiens#ligandStructureId*31564#literature*707113#!ecNumber*3.4.17.20#kmValue*0.979#kmValueMaximum*#substrate*anisylazoformyl-Lys#commentary*24&deg;C#organism*Homo sapiens#ligandStructureId*7570#literature*652361#!ecNumber*3.4.17.20#kmValue*1.089#kmValueMaximum*#substrate*anisylazoformyl-Lys#commentary*24&deg;C#organism*Homo sapiens#ligandStructureId*7570#literature*652361#!ecNumber*3.4.17.20#kmValue*1.11#kmValueMaximum*#substrate*anisylazoformyl-Lys#commentary*24&deg;C#organism*Homo sapiens#ligandStructureId*7570#literature*652361#!ecNumber*3.4.17.20#kmValue*1.12#kmValueMaximum*#substrate*hippuryl-L-Arg#commentary*#organism*Homo sapiens#ligandStructureId*2744#literature*28944#!ecNumber*3.4.17.20#kmValue*1.26#kmValueMaximum*#substrate*anisylazoformyl-Lys#commentary*24&deg;C#organism*Homo sapiens#ligandStructureId*7570#literature*652361#!ecNumber*3.4.17.20#kmValue*1.45#kmValueMaximum*#substrate*Hippuryl-L-Lys#commentary*#organism*Homo sapiens#ligandStructureId*6536#literature*28944#!ecNumber*3.4.17.20#kmValue*2.38#kmValueMaximum*#substrate*hippuryl-Arg#commentary*Vmax: 44.86 micromol/l/min#organism*Homo sapiens#ligandStructureId*3376#literature*700206#!ecNumber*3.4.17.20#kmValue*3.41#kmValueMaximum*#substrate*N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys#commentary*recombinant enzyme#organism*Homo sapiens#ligandStructureId*9224#literature*28933#!ecNumber*3.4.17.20#kmValue*3.44#kmValueMaximum*#substrate*hippuryl-Arg#commentary*Vmax: 46.05 micromol/l/min#organism*Bos taurus#ligandStructureId*3376#literature*700206#!ecNumber*3.4.17.20#kmValue*4.71#kmValueMaximum*#substrate*N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys#commentary*plasma-derived enzyme#organism*Homo sapiens#ligandStructureId*9224#literature*28933#!ecNumber*3.4.17.20#kmValue*10#kmValueMaximum*#substrate*bradykinin#commentary*#organism*Homo sapiens#ligandStructureId*466#literature*28942#!ecNumber*3.4.17.20#kmValue*63#kmValueMaximum*#substrate*Arg6-Leu5-enkephalin#commentary*#organism*Homo sapiens#ligandStructureId*29755#literature*28942#!ecNumber*3.4.17.20#kmValue*110#kmValueMaximum*#substrate*Lys6-Leu5-enkephalin#commentary*#organism*Homo sapiens#ligandStructureId*30161#literature*28942#!ecNumber*3.4.17.20#kmValue*140#kmValueMaximum*#substrate*Arg6-Met5-enkephalin#commentary*#organism*Homo sapiens#ligandStructureId*29756#literature*28942#!ecNumber*3.4.17.20#kmValue*180#kmValueMaximum*#substrate*hippuryl-L-Arg#commentary*#organism*Homo sapiens#ligandStructureId*2744#literature*28942#!ecNumber*3.4.17.20#kmValue*210#kmValueMaximum*#substrate*N-[3-(2-Furylacryloyl)]-L-Ala-L-Arg#commentary*#organism*Homo sapiens#ligandStructureId*30207#literature*28942#!ecNumber*3.4.17.20#kmValue*220#kmValueMaximum*#substrate*Lys6-Met5-enkephalin#commentary*#organism*Homo sapiens#ligandStructureId*30162#literature*28942#!ecNumber*3.4.17.20#kmValue*240#kmValueMaximum*#substrate*Hippuryl-L-argininic acid#commentary*#organism*Homo sapiens#ligandStructureId*15782#literature*28942#!ecNumber*3.4.17.20#kmValue*270#kmValueMaximum*#substrate*Hippuryl-L-Lys#commentary*#organism*Homo sapiens#ligandStructureId*6536#literature*28942#!ecNumber*3.4.17.20#kmValue*280#kmValueMaximum*#substrate*N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys#commentary*#organism*Homo sapiens#ligandStructureId*9224#literature*28942#!ecNumber*3.4.17.20#kmValue*766#kmValueMaximum*#substrate*Hippuryl-L-Lys#commentary*plasma-derived enzyme#organism*Homo sapiens#ligandStructureId*6536#literature*28933#!ecNumber*3.4.17.20#kmValue*783#kmValueMaximum*#substrate*hippuryl-L-Arg#commentary*recombinant enzyme#organism*Homo sapiens#ligandStructureId*2744#literature*28933#!ecNumber*3.4.17.20#kmValue*817#kmValueMaximum*#substrate*hippuryl-L-Arg#commentary*plasma-derived enzyme#organism*Homo sapiens#ligandStructureId*2744#literature*28933#!ecNumber*3.4.17.20#kmValue*933#kmValueMaximum*#substrate*Hippuryl-L-Lys#commentary*recombinant enzyme#organism*Homo sapiens#ligandStructureId*6536#literature*28933#